Skip to content
Search

Latest Stories

Ongoing industrial action will have a significant impact on pharmacy, warn GPhC and CPhO

Ongoing industrial action will have a significant impact on pharmacy, warn GPhC and CPhO
(Photo: iStock)

Pharmacy professionals encouraged to use their professional judgement to assess and mitigate risk as they deal with increased pressure

The General Pharmaceutical Council (GPhC) and the Chief Pharmaceutical Officer for England have written a letter to pharmacy professionals thanking them for providing the best possible services to patients and the public, despite experiencing high and sustained demands and pressures.


GPhC Chief Executive Duncan Rudkin and CPhO David Webb indicated that there will be further challenges over the coming weeks and months due to the ongoing industrial action, and staff shortages due to sickness or caring responsibilities.

They expressed concerned that increased pressure will have a significant and potentially prolonged impact on pharmacy teams both personally and professionally.

Acknowledging that pharmacy professionals may have to make some difficult decisions as they deal with the pressures they face, the leaders have urged those working in pharmacy to use “your professional judgement to assess and mitigate risk, and to deliver safe and effective care for your patients within your scope of practice.”

The letter reads: “Regulatory standards for pharmacy professionals and – where relevant – the standards for registered pharmacies are there to support you in making what may sometimes be difficult decisions. These standards are designed to be adaptable and to provide a framework for decision-making in a wide range of situations.”

Further, Duncan and David reassured that in the unlikely event that they are referred to the regulator, the context in which they were working at the time will be considered.

Employers, educational supervisors, professional bodies and national health and social care organisations are also expected to take the challenging situations pharmacy professionals may be facing into account.

Pharmacy professionals are advised to take care of their health and wellbeing, and visit the relevant NHS websites for support.

Supporting the GPhC’s statement, Community Pharmacy England (CPE) has also encouraged those who manage the pharmacy contract within NHS England and Integrated Care Systems to take a similar approach when considering issues faced by pharmacy owners during this time.

“This could be, for example, at times when pharmacies are overloaded with patients’ prescriptions due to pharmacy closures nearby, when they may not be able to dispense prescriptions as promptly as they usually do, or may even have to direct patients to other pharmacies, or undertake additional closed door working to ensure dispensing is carried out safely,” it said.

CPE is set to launch its annual Pressures Survey in March this year to capture further evidence on the unsustainable pressures being faced by those working in community pharmacy.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less